Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across ...

Stryker, Smith+Nephew, J&J, and more had ortho innovation announcements at the American Academy of Orthopaedic Surgeons (AAOS ...

Those include augment and screw planning, intraoperative screw trajectory guidance and compatibility with Stryker’s revision ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $436.46, a high estimate of ...

Stryker unveiled its updated Mako surgical robot and orthopedic companies expect procedure volumes to remain steady despite ...

Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...

intraoperative screw trajectory guidance and compatibility with Stryker's revision hip implant portfolio. These new capabilities are designed to help surgeons simplify hip procedures by knowing ...

Stryker Co. (NYSE:SYK – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty ratings ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Orthopedic device companies gathered last week in San ...

Stryker (NYSE:SYK – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on ...